The FreeStyle Libre 3 was recently approved by the FDA and has many important new features, including continuous blood sugar readings sent directly to your smartphone, better Bluetooth, improved accuracy, and a smaller, slimmer profile.
read more →
The Eversense E3 implantable CGM was recently approved by the FDA and offers a six-month wear time, the longest of any CGM on the market. Drs. E+P explain how the device works, what the implant procedure is like (they’ve both had it done), and what the unique features are of the system.
read more →
Dexcom’s G7 just received CE Mark approval in Europe, with a limited launch expected in the coming weeks. Abbott’s FreeStyle Libre 3 has been available in parts of Europe already, but it is now available for use via the NHS Supply Chain Framework in the UK and under existing eligibility criteria for real-time CGM. Here are the highlights of both systems.
read more →
The long-awaited Eversense E3 implantable CGM has been cleared by the FDA, offering twice the sensor life as the previous version. In addition to its 6-month wear time, it has other features and improvements that make it a unique and appealing CGM option.
read more →
Don’t panic if your CGM and fingerstick values don’t match – there are many reasons why this can happen. Dr. E shares the three most important things to remember when comparing CGM and fingerstick values.
read more →
